Judge: Teva not liable for Oxycontin patent violation

Share this article:

Generics and branded drugmaker Teva took a swing and won against painkiller company Purdue Pharma.

Bloomberg reports that Purdue, whose name is synonymous with Oxycontin, lost a legal battle in which it asserted that Teva's generic violated multiple patents.

US District Judge Sidney Stein agreed that Teva overstepped three patents, but said the “obvious” nature of the patents meant he was not going to hold the company liable.

Purdue told Bloomberg it will appeal the decision.

Share this article:
You must be a registered member of MMM to post a comment.

This compelling e-book shares a wealth of insights designed to help members of sales forces connect with elusive HCPs. An expanded version has also been created that includes video interviews and other multimedia content. Click here for access.